. 2016 Feb 12;30(5):1126–1132. doi: 10.1038/leu.2015.360

Table 3. Differentiation and comparison of the BSCH-defined cohort of ET patients^{1, 2} by applying the diagnostic criteria of the WHO classification³.

	BCSH-defined ET (n=238)	WHO-defined ET (n=232)
ET	141 (59.2%)	232 (100%)
prePMF	77 (32.4%)	0
PV	16 (6.7%)	0
PMF	4 (1.7%)	0

Abbreviations: BCSH, British Committee of Standards in Haematology; ET, essential thrombocythemia; PMF, advanced PMF; prePMF, prefibrotic primary myelofibrosis; PV, polycythemia vera.

Table 3. Differentiation and comparison of the BSCH-defined cohort of ET patients 1, 2 by applying the diagnostic criteria of the WHO classification 3 .

Table 3. Differentiation and comparison of the BSCH-defined cohort of ET patients^{1, 2} by applying the diagnostic criteria of the WHO classification³.